HUP9602024A2 - Aminosavtartalmú, külsőlegesen használható, gyógyhatású készítmény - Google Patents

Aminosavtartalmú, külsőlegesen használható, gyógyhatású készítmény

Info

Publication number
HUP9602024A2
HUP9602024A2 HU9602024A HUP9602024A HUP9602024A2 HU P9602024 A2 HUP9602024 A2 HU P9602024A2 HU 9602024 A HU9602024 A HU 9602024A HU P9602024 A HUP9602024 A HU P9602024A HU P9602024 A2 HUP9602024 A2 HU P9602024A2
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition containing
external use
inflammatory
containing aminoacid
Prior art date
Application number
HU9602024A
Other languages
English (en)
Inventor
Sándor Tóth
Original Assignee
Sándor Tóth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sándor Tóth filed Critical Sándor Tóth
Priority to HU9602024A priority Critical patent/HUP9602024A3/hu
Publication of HU9602024D0 publication Critical patent/HU9602024D0/hu
Priority to DE69733539T priority patent/DE69733539D1/de
Priority to EP97929442A priority patent/EP0855915B1/en
Priority to CA002232710A priority patent/CA2232710A1/en
Priority to AT97929442T priority patent/ATE297752T1/de
Priority to PCT/HU1997/000035 priority patent/WO1998004280A2/en
Priority to AU33549/97A priority patent/AU3354997A/en
Priority to US09/043,657 priority patent/US6048843A/en
Priority to HRP9602024A priority patent/HRP970419A2/hr
Publication of HUP9602024A2 publication Critical patent/HUP9602024A2/hu
Publication of HUP9602024A3 publication Critical patent/HUP9602024A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya aminősavtartalmú, különlegesen használhatógyógyhatású készítmény, amely előnyösen pőtencírőzó, antivirális,gyűlladáscsökkentő hatással rendelezik, tővábbá pszőriázis tüneteinekgyógyítására alkalmas. A készítményt az jellemzi, hőgy az alábbi csőpőrtba tartőzó aminősavakvalamelyikét - D- vagy L- aszparaginsav, cisztein, cisztin, glőcin,őxiprőlin, szerin, tirőzin - vagy ezek keverékét, tővábbá kívántesetben interferőnt, timidinanalóg herpeszellenes vegyületeket,előnyösen űridinszámazékőkat, valamint ismert gyógyszerészetiadalékanyagőkat, előnyösen őlószert, kőnzerválószert vagy ismertkenőcsalapőt - tartalmaz. ŕ
HU9602024A 1996-07-25 1996-07-25 Pharmaceutical composition containing aminoacid for external use HUP9602024A3 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HU9602024A HUP9602024A3 (en) 1996-07-25 1996-07-25 Pharmaceutical composition containing aminoacid for external use
US09/043,657 US6048843A (en) 1996-07-25 1997-07-03 Topical composition containing amino acid in combination with either interferon of thymidine derivatives for treating viral or inflammation diseases
AT97929442T ATE297752T1 (de) 1996-07-25 1997-07-03 Topische mittel, die eine aminosäure in kombination mit entweder interferon oder mit thymidinderivaten enthalten, zur behandlung viraler oder entzündlicher erkrankungen
EP97929442A EP0855915B1 (en) 1996-07-25 1997-07-03 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
CA002232710A CA2232710A1 (en) 1996-07-25 1997-07-03 Medically beneficial preparation for topical use containing amino acids
DE69733539T DE69733539D1 (de) 1996-07-25 1997-07-03 Topische mittel, die eine aminosäure in kombination mit entweder interferon oder mit thymidinderivaten enthalten, zur behandlung viraler oder entzündlicher erkrankungen
PCT/HU1997/000035 WO1998004280A2 (en) 1996-07-25 1997-07-03 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
AU33549/97A AU3354997A (en) 1996-07-25 1997-07-03 Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
HRP9602024A HRP970419A2 (en) 1996-07-25 1997-07-24 Medically beneficial preparation for outer use containing amino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9602024A HUP9602024A3 (en) 1996-07-25 1996-07-25 Pharmaceutical composition containing aminoacid for external use

Publications (3)

Publication Number Publication Date
HU9602024D0 HU9602024D0 (en) 1996-09-30
HUP9602024A2 true HUP9602024A2 (hu) 1998-03-30
HUP9602024A3 HUP9602024A3 (en) 1999-05-28

Family

ID=89994154

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9602024A HUP9602024A3 (en) 1996-07-25 1996-07-25 Pharmaceutical composition containing aminoacid for external use

Country Status (9)

Country Link
US (1) US6048843A (hu)
EP (1) EP0855915B1 (hu)
AT (1) ATE297752T1 (hu)
AU (1) AU3354997A (hu)
CA (1) CA2232710A1 (hu)
DE (1) DE69733539D1 (hu)
HR (1) HRP970419A2 (hu)
HU (1) HUP9602024A3 (hu)
WO (1) WO1998004280A2 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100394382B1 (ko) * 1996-02-28 2004-02-05 유니하트 코포레이션 천연사람α-인터페론으로구성된약학조성물
US7396526B1 (en) 1998-11-12 2008-07-08 Johnson & Johnson Consumer Companies, Inc. Skin care composition
JP2003516360A (ja) * 1999-12-09 2003-05-13 カイロン コーポレイション 中枢神経系およびリンパ系に対するサイトカイン投与方法
US6415797B1 (en) * 2000-07-07 2002-07-09 First Circle Medical, Inc. Treatment of human herpesviruses using hyperthermia
KR20020027198A (ko) * 2000-10-02 2002-04-13 차알스 제이. 메츠 염증과 홍반의 완화방법
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
JP4382354B2 (ja) * 2001-03-13 2009-12-09 ヴァルブルク・グリコムド・ゲーエムベーハー １−ブタン酸誘導体およびその使用
DE10112924A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710376A (en) * 1985-02-01 1987-12-01 Interferon Sciences, Inc. Topical therapeutic composition containing oxidation inhibitor system
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
ATE90570T1 (de) * 1988-01-29 1993-07-15 Sumitomo Pharma Verbesserte formulierungen mit kontrollierter abgabe.
CA1339256C (en) * 1989-01-26 1997-08-12 Wulf Droge Treatment of diseases associated with hiv-infections

Also Published As

Publication number Publication date
US6048843A (en) 2000-04-11
HRP970419A2 (en) 1998-08-31
ATE297752T1 (de) 2005-07-15
WO1998004280A3 (en) 1998-03-26
DE69733539D1 (de) 2005-07-21
AU3354997A (en) 1998-02-20
CA2232710A1 (en) 1998-02-05
WO1998004280A2 (en) 1998-02-05
EP0855915B1 (en) 2005-06-15
HUP9602024A3 (en) 1999-05-28
HU9602024D0 (en) 1996-09-30
EP0855915A2 (en) 1998-08-05

Similar Documents

Publication Publication Date Title
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
DK0760677T3 (da) Farmaceutisk præparat omfattende glucagon
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
ES8706169A1 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
DE69839812D1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
ATE136221T1 (de) Osteo-induktive pharmazeutische formulierungen
HUP0000589A2 (hu) Vizes peptid készítmények
ES2163444T3 (es) Composiciones y metodos para la administracion oral de farmacos.
ATE244015T1 (de) Formulierungen fuer faktor ix
IE823046L (en) Stabilised interferon formulations
ES2150916T3 (es) Utilizacion del acido gentisico o del alcohol gentisilico para estabilizar peptidos y proteinas radiomarcados.
BR9807076B1 (pt) "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica"
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
BR9807618A (pt) Análogo de fator xdelta, dna recombinante codificante para um análogo de fator xdelta, células transformadas, preparação, uso da mesma, e, processos para produzir uma preparação contendo análogo de fator xdelta recombinante purificado e análogo de fator xa.
IT1272290B (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
HUP9602024A2 (hu) Aminosavtartalmú, külsőlegesen használható, gyógyhatású készítmény
IT1274156B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
WO2002048180A3 (de) Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels
CA2334941A1 (en) Tnf-derived peptides for use in treating oedema
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
DE69430416D1 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
AR036591A1 (es) Uso de la hl en hiperestimulacion ovarica controlada
ATE371737T1 (de) Proteaseresistente flint-analoge
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees